arrow
L

Lawrence B. Schwartz

Universite Paris Cite
H-index:101
Citation Count:3.3万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
2024-12-012
OAAI
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination
2024-06-011
OAAI
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

基线类胰蛋白酶的正常范围应为1至15 ng/mL,并涵盖患有h α t的健康个体

2023-10-0122
OAAI
Fluoxetine restrains allergic inflammation by targeting an FcRI-ATP positive feedback loop in mast cells
2023-09-121
OA
Inhibiting Isoprenylation Suppresses FcεRI-Mediated Mast Cell Function and Allergic Inflammation
2023-07-144
OA
Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
2023-04-2822
OAAI
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
2022-08-0114
OAAI
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
2022-08-0139
OAAI
Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis

定义血清类胰蛋白酶水平的基线变异性可提高识别过敏反应的准确性

2022-03-0146
OAAI
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
2021-11-01169
OAAI
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
2021-11-0139
OAAI
Mast Cell Activation During Suspected Perioperative Hypersensitivity: A Need for Paired Samples Analysis
2021-08-0116
OAAI
Proceedings from the Inaugural American Initiative in Mast Cell Diseases(AIM) Investigator Conference

首届美国肥大细胞疾病倡议 (AIM) 研究者会议论文集

2021-06-0111
OAAI
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
2021-06-0135
OAAI
Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1
2021-02-01149
PREAI
Fluvastatin Induces Apoptosis in Primary and Transformed Mast Cells
2020-07-017
OAAI
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts
2020-01-01124
OAAI
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management

AAAAI肥大细胞疾病委员会工作组报告: 肥大细胞活化综合征 (MCAS) 的诊断和管理

2019-10-0168
OAAI
Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia
2019-07-2391
OAAI
IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis
2019-05-1483
OA